SHC014748M

赛博利塞

Report date: 2023/05/05 17:09:39
NME

Base Information

Drug NameSHC014748M
Drug Alias NameSHC-014748M
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Follicular +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNanjing Sanhome Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Sanhome Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Follicular +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A